|Articles|April 19, 2019
Bioclinica Launches NAFLD/NASH Practice
Advertisement
Bioclinica has announced that is has assembled a team of experts dedicated to nonalcoholic fatty liver disease and nonalcoholic steatohepatitis to help sponsors develop therapeutics using medical imaging and other biomarkers in clinical trials.
Read more about it
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
A Shot in the Arm to Traditional Vaccine Trial Strategy
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
5